Meningitis Diagnosis & Treatment Market, By Type (Fungal, Viral and Bacterial), By Diagnostic Test (Lateral Flow Assay, PCR Assay, Latex Agglutination Tests, Elisa Tests and Culture Tests), By End-User (Hospitals, Clinics and Others), and By Region (North America, Europe, Asia Pacific, Latin America, AND Middle East & Africa) - Market Trends, Analysis, and Forecast Till 2030

The inflammation of the meninges is known as meningitis. The three membranes that protect the brain and spinal cord are known as the meninges. When the fluid covering the meninges becomes infected, meningitis may develop. Viruses, fungi, and bacteria are the most common causes of meningitis. If left untreated, the disease can be fatal, so prompt treatment is needed to keep it under control. Each form of meningitis has a different cause, but they all have the same symptoms.. Noninfectious meningitis is caused by a physical injury or another disease rather than an infection. HIV, tuberculosis, and some illnesses may also cause meningitis. Meningitis Diagnosis and Treatment Market accounted for US$ 126.6 million in 2020 and is estimated to be US$ 192.9 million by 2030 and is anticipated to register a CAGR of 4.3%.

Impact of covid 19 Pandemic on market

The COVID-19 outbreak, which started in December 2019, has spread to nearly every country across the world, causing the WHO to declare it a public health emergency. In the ongoing COVID-19 pandemic, bacterial co-infection is linked to bad outcomes, but the cause is unknown. The control of bacterial co-infection in COVID-19 poses significant antimicrobial stewardship and clinical management challenges. Meningococcal meningitis is caused by the Gram-negative diplococcus Neisseria meningitidis, which can only be detected in the human nasopharynx. While antibiotics are commonly prescribed in the context of severe COVID-19, the function of bacterial co-infection is unclear.

Rising initiatives by government bodies

Meningitis is a fatal and incapacitating disease that strikes suddenly, has severe health, economic, and social effects, and affects people of all ages in all countries. Bacterial meningitis has the potential to spread epidemics, cause death within 24 hours, and leave one out of every five patients disabled for the rest of their lives. Meningitis is vaccine preventable in many cases and deaths, but success in eradicating the disease lags behind other vaccine-preventable diseases. Governments, global health agencies, public health organisations, academia, the private sector, and civil society leaders all called for a global vision to eliminate meningitis as a public health problem in 2017. The WHO responded to the call to action by developing a road map to eliminate meningitis by 2030 in collaboration with partners and experts involved in the disease's prevention and control. Throughout 2019, there were several public and expert consultations.

Growth in business operations by emerging and small sized players

The growing prevalence of meningitis as well as increased efforts to tackle the disease, such as efforts to minimize the disease's incidence and better control the disease are driving the meningitis diagnosis and treatment market. Over the forecast period, growing demand for point-of-care diagnostic services, especially for chronic diseases, is expected to be a major driver of the meningitis diagnosis and treatment market. Growing investments in R&D for effective diagnosis and treatment of such a critical disease, as well as an increase in the number of cases of meningitis, are expected to propel the market forward. Other factors driving market growth include the introduction of new technologies and products, as well as the continued expansion of the medical device industry.

Meningitis Diagnosis and treatment market is segmented based on type, diagnostic tests, end-user and region.

On the basis of type, the Meningitis diagnosis and treatment market is segmented into fungal bacterial and viral. Based on Diagnostics tests, the target market is segmented into lateral flow assay, PCR assay, latex agglutination tests, ELISA tests and culture tests. On the basis of end-user, the target market is segmented into hospitals, clinics and others.

Regional Insights:

On region the meningitis diagnosis and treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market for meningitis diagnosis and care, with the largest market shares. The demand in North America is expected to rise due to a fast adoption rate of advanced medical devices, easy availability of diagnostic test kits, and a high number of cases of viral meningitis.

Report Scope:

Attribute	Details
Base year for estimation	2020
Forecast period	2020 – 2030
Market representation	Revenue in USD Million & CAGR from 2020 – 2030
Market Segmentation	By type- Fungal Bacterial And Viral By diagnostic tests– Lateral Flow Assay, PCR Assay, Latex Agglutination Tests, ELISA Tests and Culture Tests. By End-user– Hospitals, Clinics And Others
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2030. For the purpose of this study, has segmented the meningitis diagnosis and treatment market report based on type, diagnostic test, end-user, and region.

                                                                 

Meningitis Diagnosis and Treatment Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating in the meningitis diagnosis and treatment market includes Thermo Fisher Scientific, Inc., Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers, Bio-Rad Laboratories, Inc., IMMY, BioFire Diagnostics, Nanosphere (Luminex Corporation), Seegene Inc., Qnostics, ELITechGroup, and Abbott Laboratories. To meet the needs of their customers, these industry leaders are launching new goods. To broaden their customer base and strengthen their market presence, players are entering new markets in emerging regions.

• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Fast Track diagnostic ltd.
• Siemens Healthineers
• Bio-Rad laboratories Inc.
• IMMY
• BioFire Diagnostics
• Nanosphere (Luminex Corporation)
• Seegene Inc.
• Qnostics
• ELITechGroup
• Abbott Laboratories

“*” marked represents similar segmentation in other categories in the respective section

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Preview
   • Executive Summary
   • Key Findings—Global Outlook for Meningitis diagnosis and treatment Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Type
     • Market Snippet, By Diagnostic tests
     • Market Snippet, By End-User
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Market segmentation, By Type,  2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Fungal
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Bacterial
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Viral
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
6. Market segmentation, By Diagnostic tests, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Lateral flow assay
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • PCR assay
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Latex agglutination tests
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • ELISA tests
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
7. Market segmentation, By End-use,, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Hospital
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Clinics
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Others
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
8. Global Market, By Region, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Diagnostic tests, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Diagnostic tests, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • UK
       • France
       • Germany
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Diagnostic tests, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • India
       • Japan
       • South Korea
       • China
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Diagnostic tests, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • Brazil
       • Mexico
       • Rest of Latin America
   • Middle East & Africa
     • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Diagnostic tests, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • GCC
       • Israel
       • South Africa
       • Rest of Middle East
9. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
10. Company Profiles

• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Fast Track diagnostic ltd.
• Siemens Healthineers
• Bio-Rad laboratories Inc.
• IMMY
• BioFire Diagnostics
• Nanosphere (Luminex Corporation)
• Seegene Inc.
• Qnostics
• ELITechGroup
• Abbott Laboratories

The Last Word

• Future Impact
• About Us
• Contact